design of the zuma-1 trial in non-hodgkin lymphoma
Published 6 years ago • 52 plays • Length 0:53Download video MP4
Download video MP3
Similar videos
-
2:03
long-term follow-up results from the zuma-1 trial in non-hodgkin lymphoma
-
2:24
dr. neelapu on axi-cel in the zuma-1 trial for refractory aggressive non-hodgkin lymphoma
-
2:02
discussing the results from the zuma-1 trial for patients with advanced lymphoma
-
2:02
dr. neelapu on updated zuma-1 findings in non-hodgkin lymphoma
-
2:48
zuma-1: safety and efficacy of axicabtagene in refractory non-hodgkin lymphoma patients
-
4:57
pd-1 inhibition in hodgkin’s lymphoma
-
2:00
long-term follow-up results of the zuma-1 trial of anti-cd19 car t-cells for non-hodgkin lymphoma
-
3:41
interim results from the zuma-1 trial of novel car-t cells against non-hodgkin lymphoma
-
8:01
high-risk lymphoma: the zuma-1 and scholar-1 trials
-
1:52
long-term results of zuma-1 trial for patients with nhl
-
12:21
non-hodgkin lymphoma - causes, symptoms, diagnosis, treatment, pathology
-
1:14
results of the zuma-1 trial exploring kte-c19 in nhl
-
13:35
usmle hematology and oncology 7 non-hodgkin lymphomas
-
3:31
zuma-1 trial observations
-
4:07
hodgkin lymphoma & non-hodgkin lymphoma treatment
-
0:46
key takeaway from 2-year follow-up data of zuma-1 trial in large b-cell lymphoma
-
7:19
lymphoma – an introduction
-
6:45
differential diagnosis for follicular lymphoma
-
1:15
discussing the evolution of immunotherapy in lymphomas